Pembrolizumab before surgery led to a significant increase in patients being declared cancer-free in a trial, potentially revolutionizing the treatment approach.
Immunotherapy could replace the need for conventional chemotherapy in the future, offering better outcomes and fewer side effects for bowel cancer patients.
Collection
[
|
...
]